肾膀胱超声可否替代CT尿路造影用于显微镜血尿检查
DETECT I 前瞻性研究纳入3556例血尿患者,比较肾膀胱超声与CT尿路造影诊断尿路肿瘤的准确性。显微镜血尿患者上尿路尿路上皮癌发生率为0%,超声对肾癌敏感度85.7%、阴性预测值99.9%,对膀胱癌敏感度低于CT尿路造影。结论为显微镜血尿患者可用肾膀胱超声安全替代CT尿路造影,肉眼血尿患者上尿路尿路上皮癌发生率0.8%仍推荐CT尿路造影。
要点
- 显微镜血尿患者上尿路尿路上皮癌发生率为0%,可用肾膀胱超声替代CT尿路造影。
- 肉眼血尿患者上尿路尿路上皮癌发生率0.8%,仍推荐CT尿路造影。
- 怀疑肾结石者需行非增强肾尿路CT,影像不能替代膀胱镜诊断膀胱癌。
核心结论
- 显微镜血尿患者可用肾膀胱超声安全替代CT尿路造影。
- 肉眼血尿患者上尿路尿路上皮癌发生率为0.8%,推荐CT尿路造影。
- 影像检查不能替代膀胱镜诊断膀胱癌。
研究设计与样本
- DETECT I 为前瞻性观察性研究,在40家医院招募18岁及以上肉眼或显微镜血尿患者。
- 共纳入3556例患者,中位年龄68岁,2166例行肾膀胱超声,1692例行CT尿路造影,均行膀胱镜检查。
主要发现
- 肉眼血尿患者膀胱癌、肾癌、上尿路尿路上皮癌发生率分别为11.0%、1.4%、0.8%。
- 显微镜血尿患者膀胱癌、肾癌、上尿路尿路上皮癌发生率分别为2.7%、0.4%、0%。
- 肾膀胱超声检测肾癌的敏感度和阴性预测值分别为85.7%和99.9%,检测上尿路尿路上皮癌分别为14.3%和99.7%。
- 肾膀胱超声对肾结石识别能力差,检测膀胱癌的敏感度低于CT尿路造影(两者均低于85%)。
- 膀胱镜特异度为98.3%,阳性预测值为83.9%。
关键数值与推荐
- 显微镜血尿患者上尿路尿路上皮癌发生率为0%,肾膀胱超声对肾癌阴性预测值99.9%。
- 肉眼血尿患者上尿路尿路上皮癌发生率为0.8%,推荐CT尿路造影。
- 怀疑肾结石者需行非增强肾尿路CT。
- 膀胱镜特异度98.3%、阳性预测值83.9%,影像不能替代膀胱镜。
临床怎么用
- 显微镜血尿患者可首选肾膀胱超声替代CT尿路造影进行上尿路评估。
- 肉眼血尿患者仍应行CT尿路造影以排查上尿路尿路上皮癌。
- 怀疑肾结石时应行非增强肾尿路CT而非依赖超声。
- 膀胱癌诊断仍需膀胱镜检查,影像检查不能替代。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Computerized tomography urogram is recommended when investigating patients with hematuria. We determined the incidence of urinary tract cancer and compared the diagnostic accuracy of computerized tomography urogram to that of renal and bladder ultrasound for identifying urinary tract cancer. MATERIALS AND METHODS: The DETECT (Detecting Bladder Cancer Using the UroMark Test) I study is a prospective observational study recruiting patients 18 years old or older following presentation with macroscopic or microscopic hematuria at a total of 40 hospitals. All patients underwent cystoscopy and upper tract imaging comprising computerized tomography urogram and/or renal and bladder ultrasound. RESULTS: A total of 3,556 patients with a median age of 68 years were recruited in this study, of whom 2,166 underwent renal and bladder ultrasound, and 1,692 underwent computerized tomography urogram in addition to cystoscopy. The incidence of bladder, renal and upper tract urothelial cancer was 11.0%, 1.4% and 0.8%, respectively, in macroscopic hematuria cases. Patients with microscopic hematuria had a 2.7%, 0.4% and 0% incidence of bladder, renal and upper tract urothelial cancer, respectively. The sensitivity and negative predictive value of renal and bladder ultrasound to detect renal cancer were 85.7% and 99.9% but they were 14.3% and 99.7%, respectively, to detect upper tract urothelial cancer. Renal and bladder ultrasound was poor at identifying renal calculi. Renal and bladder ultrasound sensitivity was lower than that of computerized tomography urogram to detect bladder cancer (each less than 85%). Cystoscopy had 98.3% specificity and 83.9% positive predictive value. CONCLUSIONS: Computerized tomography urogram can be safely replaced by renal and bladder ultrasound in patients who have microscopic hematuria. The incidence of upper tract urothelial cancer is 0.8% in patients with macroscopic hematuria and computerized tomography urogram is recommended. Patients with suspected renal calculi require noncontrast renal tract computerized tomography. Imaging cannot replace cystoscopy to diagnose bladder cancer.
引用
- Tan WS, Sarpong R, Khetrapal P, et al. Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria? J Urol. 2018. PMID: 29702097. doi:10.1016/j.juro.2018.04.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。